WITNESSETH:Employment Agreement • May 14th, 1997 • Amdl Inc • Blank checks • California
AMDL, INC.Employment Agreement • March 30th, 2000 • Amdl Inc • Blank checks • California
Exhibit 10.33 Employment Agreement Between the Company and Harry Berk Dated January 1, 1997 EMPLOYMENT AGREEMENT This Employment Agreement (the "Agreement") is made and entered into this 1st day of January 1997, by and between AMDL, Inc.. a Delaware...Employment Agreement • May 14th, 1997 • Amdl Inc • Blank checks • California
AMDL, INC.Securities Purchase Agreement • October 15th, 1999 • Amdl Inc • Blank checks • Delaware
AMDL, INC.Securities Purchase Agreement • March 30th, 2000 • Amdl Inc • Blank checks • Delaware
AMDL, INC. EMPLOYMENT AGREEMENTEmployment Agreement • June 19th, 1998 • Amdl Inc • Blank checks • California
RECITALSPlacement Agent Agreement • January 10th, 2002 • Amdl Inc • Blank checks • California
WITNESSETH:Employment Agreement • May 14th, 1997 • Amdl Inc • Blank checks • California
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 2nd, 2009 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of November 30, 2009, between Radient Pharmaceuticals Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCK PURCHASE WARRANT RADIENT PHARMACEUTICALS CORPORATIONCommon Stock Purchase Warrant • December 2nd, 2009 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May __, 2010 (the “Initial Exercise Date”) and on or prior to the close of business on the six and one half year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Radient Pharmaceuticals Corporation, a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 31st, 2011 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of January 30, 2011, by and among Radient Pharmaceuticals Corporation, Delaware corporation, with headquarters located at 2492 Walnut Avenue, Suite 100, Tustin, California 92780 (the "Company"), and the investors listed on the Schedule of Buyers attached hereto (each, a "Buyer" and collectively, the "Buyers").
RECITALSExclusive Distribution Agreement • December 27th, 2000 • Amdl Inc • Blank checks • California
BETWEEN AMDL, INC. ANDSecurities Purchase Agreement • December 27th, 2000 • Amdl Inc • Blank checks • California
1,644,643 Units RADIENT PHARMACEUTICALS CORPORATION (F/K/A AMDL, INC.) CONSISTING OF COMMON STOCK (PAR VALUE $0.001) AND WARRANTS WITH AN EXERCISE PRICE OF $1.25 PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • December 2nd, 2009 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
1 EXHIBIT 2.1 TECHNOLOGY TRANSFER AGREEMENT This TECHNOLOGY TRANSFER AGREEMENT ("Agreement") is entered into effective July 30, 2001, by and between AMDL, INC., a Delaware corporation ("AMDL"), and LUNG-JI CHANG, Ph.D., an individual resident of...Technology Transfer Agreement • September 17th, 2001 • Amdl Inc • Blank checks • California
AGREEMENTDirector Agreement • August 14th, 1998 • Amdl Inc • Blank checks • California
FORM OF WARRANT] RADIENT PHARMACEUTICALS CORPORATION Warrant To Purchase Common StockWarrant to Purchase Common Stock • July 1st, 2011 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
Radient Pharmaceuticals Corporation, a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [_____________], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after the Issuance Date, but not after 11:59 p.m., New York time, on the Expiration Date, (as defined below), ______________ (_____________) fully paid, nonassessable shares of Common Stock (as defined below), subject to adjustment as provided herein (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, this “Warrant”), shall have the meanings set forth in Section 17. This Warrant
1 Exhibit 10.60 VOTING TRUST AGREEMENT THIS VOTING TRUST AGREEMENT is made and entered into by and between JEANNE LAI AND GARY L. DREHER, as Co-Trustees (hereinafter, with any successor Trustees, collectively referred to as the "Trustees") and CHINESE...Voting Trust Agreement • December 27th, 2000 • Amdl Inc • Blank checks • Delaware
FORM OF SERIES A WARRANT] RADIENT PHARMACEUTICALS CORPORATION Warrant To Purchase Common StockWarrant Agreement • November 29th, 2011 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
Radient Pharmaceuticals Corporation, a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [_____________], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after the Issuance Date, but not after 11:59 p.m., New York time, on the Expiration Date, (as defined below), ______________ (_____________) fully paid, nonassessable shares of Common Stock (as defined below), subject to adjustment as provided herein (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, this “Warrant”), shall have the meanings set forth in Section 17. This Warrant
NOTE AND WARRANT PURCHASE AGREEMENTNote and Warrant Purchase Agreement • April 13th, 2010 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • Illinois
THIS NOTE AND WARRANT PURCHASE AGREEMENT, dated as of April 7, 2010 (this “Agreement”), is entered into by and between RADIENT PHARMACEUTICALS CORPORATION, a Delaware corporation with headquarters located at 2492 Walnut Ave., Suite 100
AGREEMENT RELATING TO SALARY DEFERRAL DATED JULY 1, 1998 WITH HARRY BERKSalary Deferral Agreement • August 14th, 1998 • Amdl Inc • Blank checks
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 13th, 2010 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • Illinois
This Registration Rights Agreement (this “Agreement”) dated as of April 7, 2010, is made by and between Radient Pharmaceuticals Corporation, a Delaware corporation located at 2492 Walnut Ave., Tustin, California 92780 (the “Company”), and _______________________________________________ (the “Investor”).
EXHIBIT 99.1 INVESTMENT BANKING AGREEMENT This AGREEMENT, made this 9th day of December 2002 is between AMDL Inc., having its principal of business at 2492 Walnut Avenue, Suite 100, Tustin, California 92780, hereinafter the "Company" and Delta Asset...Investment Banking Agreement • December 23rd, 2002 • Amdl Inc • Blank checks • New York
ContractWarrant Agreement • October 8th, 2010 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • Illinois
THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SUCH ACT AND ANY APPLICABLE STATE SECURITIES LAW OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO RADIENT PHARMACEUTICALS CORPORATION THAT SUCH REGISTRATION IS NOT REQUIRED.
EXHIBIT 10.49 AGREEMENT REGARDING CANCELLATION OF INDEBTEDNESS This Agreement Regarding Cancellation of Indebtedness ("Agreement") is made as of this 1st day of July, 1999 by and between Thomas V. Tilton ("Holder") and AMDL, Inc., a Delaware...Agreement Regarding Cancellation of Indebtedness • October 15th, 1999 • Amdl Inc • Blank checks • Delaware
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 31st, 2011 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of January 30, 2011, by and among Radient Pharmaceuticals Corporation, Delaware corporation, with headquarters located at 2492 Walnut Avenue, Suite 100, Tustin, California 92780 (the "Company") and the investors listed on the Schedule of Buyers attached hereto (individually, a "Buyer" and collectively, the "Buyers").
R E C I T A L SEmployment Agreement • August 14th, 1998 • Amdl Inc • Blank checks
1 Exhibit 10.59 SECURITY AND PLEDGE AGREEMENT THIS SECURITY AND PLEDGE AGREEMENT ("Agreement") is entered into as of December 14, 2000 ("Effective Date"), by and among AMDL, Inc., a Delaware corporation ("Company"), OPPENHEIMER WOLFF & DONNELLY LLP...Security and Pledge Agreement • December 27th, 2000 • Amdl Inc • Blank checks • California
I RECITALSSalary Continuation Agreement • August 14th, 1998 • Amdl Inc • Blank checks • California
AgreementSettlement Agreement • November 29th, 2011 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
THIS AGREEMENT (“Agreement”) is made and entered into this 28th day of November, 2011 between Whalehaven Capital Fund, Ltd. (“Whalehaven”) and Radient Pharmaceuticals Corporation (“RPC” or the “Company”). Whalehaven is hereinafter sometimes referred to as “Holder”, Whalehaven and RPC are hereinafter sometimes individually referred to as a “Party” and collectively as the “Parties.”
AMENDMENT NO. 2 TO ESCROW AGREEMENTEscrow Agreement • March 31st, 2008 • Amdl Inc • Surgical & medical instruments & apparatus
This Amendment No. 2 to Escrow Agreement is made this 11th day of March, 2008, by and among AMDL, Inc., a Delaware corporation (“Buyer”), Jade Capital Group Limited, a British Virgin Islands corporation (“Jade Capital”), Pearl King Global Limited (“Pearl King”), and Homing Nominees Limited (“Homing”) (collectively Pearl King and Homing are referred to as “Shareholders”) and Louis Taubman, Esquire (in his capacity as Escrow Holder hereunder, the “Escrow Holder”).
EXCHANGE AGREEMENTExchange Agreement • January 24th, 2011 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • Illinois
This Exchange Agreement (the “Agreement”) is dated as of January 21, 2011, by and between Radient Pharmaceuticals Corporation, a Delaware corporation (the “Company”), and Hudson Bay Fund, LP (the “Holder”).
AMENDMENT NO. 2 TO ESCROW AGREEMENTEscrow Agreement • April 15th, 2009 • Amdl Inc • Pharmaceutical preparations
This Amendment No. 2 to Escrow Agreement is made this 11th day of March, 2008, by and among AMDL, Inc., a Delaware corporation (“Buyer”), Jade Capital Group Limited, a British Virgin Islands corporation (“Jade Capital”), Pearl King Global Limited (“Pearl King”), and Homing Nominees Limited (“Homing”) (collectively Pearl King and Homing are referred to as “Shareholders”) and Louis Taubman, Esquire (in his capacity as Escrow Holder hereunder, the “Escrow Holder”).
I RECITALSSalary Continuation Agreement • August 14th, 1998 • Amdl Inc • Blank checks • California
September 24, 2010Note and Warrant Purchase Agreement • October 5th, 2010 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations
Re: Note and Warrant Purchase Agreement and related Convertible Promissory Note between the entities listed on Exhibit A hereto (each, a “Note Holder” and, collectively, the “Note Holders”), and Radient Pharmaceuticals Corporation, a Delaware corporation (the “Company”).
